American Cancer Society Guideline for Human Papillomavirus (HPV) Vaccine Use to Prevent Cervical Cancer and Its Precursors

Debbie Saslow, Philip E. Castle, J. Thomas Cox, Diane D. Davey, Mark H. Einstein, Daron Gale Ferris, Sue J. Goldie, Diane M. Harper, Walter Kinney, Anna Barbara Moscicki, Kenneth L. Noller, Cosette M. Wheeler, Terri Ades, Kimberly S. Andrews, Mary K. Doroshenk, Kelly Green Kahn, Christy Schmidt, Omar Shafey, Robert A. Smith, Edward E. Partridge & 1 others Francisco Garcia

Research output: Contribution to journalReview article

390 Citations (Scopus)

Abstract

The American Cancer Society (ACS) has developed guidelines for the use of the prophylactic human papillomavirus (HPV) vaccine for the prevention of cervical intraepithelial neoplasia and cervical cancer. These recommendations are based on a formal review of the available evidence. They address the use of prophylactic HPV vaccines, including who should be vaccinated and at what age, as well as a summary of policy and implementation issues. Implications for screening are also discussed.

Original languageEnglish (US)
Pages (from-to)7-28
Number of pages22
JournalCa-A Cancer Journal for Clinicians
Volume57
Issue number1
DOIs
StatePublished - Jan 1 2007

Fingerprint

Papillomavirus Vaccines
Uterine Cervical Neoplasms
Guidelines
Cervical Intraepithelial Neoplasia

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this

American Cancer Society Guideline for Human Papillomavirus (HPV) Vaccine Use to Prevent Cervical Cancer and Its Precursors. / Saslow, Debbie; Castle, Philip E.; Cox, J. Thomas; Davey, Diane D.; Einstein, Mark H.; Ferris, Daron Gale; Goldie, Sue J.; Harper, Diane M.; Kinney, Walter; Moscicki, Anna Barbara; Noller, Kenneth L.; Wheeler, Cosette M.; Ades, Terri; Andrews, Kimberly S.; Doroshenk, Mary K.; Kahn, Kelly Green; Schmidt, Christy; Shafey, Omar; Smith, Robert A.; Partridge, Edward E.; Garcia, Francisco.

In: Ca-A Cancer Journal for Clinicians, Vol. 57, No. 1, 01.01.2007, p. 7-28.

Research output: Contribution to journalReview article

Saslow, D, Castle, PE, Cox, JT, Davey, DD, Einstein, MH, Ferris, DG, Goldie, SJ, Harper, DM, Kinney, W, Moscicki, AB, Noller, KL, Wheeler, CM, Ades, T, Andrews, KS, Doroshenk, MK, Kahn, KG, Schmidt, C, Shafey, O, Smith, RA, Partridge, EE & Garcia, F 2007, 'American Cancer Society Guideline for Human Papillomavirus (HPV) Vaccine Use to Prevent Cervical Cancer and Its Precursors', Ca-A Cancer Journal for Clinicians, vol. 57, no. 1, pp. 7-28. https://doi.org/10.3322/canjclin.57.1.7
Saslow, Debbie ; Castle, Philip E. ; Cox, J. Thomas ; Davey, Diane D. ; Einstein, Mark H. ; Ferris, Daron Gale ; Goldie, Sue J. ; Harper, Diane M. ; Kinney, Walter ; Moscicki, Anna Barbara ; Noller, Kenneth L. ; Wheeler, Cosette M. ; Ades, Terri ; Andrews, Kimberly S. ; Doroshenk, Mary K. ; Kahn, Kelly Green ; Schmidt, Christy ; Shafey, Omar ; Smith, Robert A. ; Partridge, Edward E. ; Garcia, Francisco. / American Cancer Society Guideline for Human Papillomavirus (HPV) Vaccine Use to Prevent Cervical Cancer and Its Precursors. In: Ca-A Cancer Journal for Clinicians. 2007 ; Vol. 57, No. 1. pp. 7-28.
@article{5c1e31cae31e43709c2aeb832b4a855f,
title = "American Cancer Society Guideline for Human Papillomavirus (HPV) Vaccine Use to Prevent Cervical Cancer and Its Precursors",
abstract = "The American Cancer Society (ACS) has developed guidelines for the use of the prophylactic human papillomavirus (HPV) vaccine for the prevention of cervical intraepithelial neoplasia and cervical cancer. These recommendations are based on a formal review of the available evidence. They address the use of prophylactic HPV vaccines, including who should be vaccinated and at what age, as well as a summary of policy and implementation issues. Implications for screening are also discussed.",
author = "Debbie Saslow and Castle, {Philip E.} and Cox, {J. Thomas} and Davey, {Diane D.} and Einstein, {Mark H.} and Ferris, {Daron Gale} and Goldie, {Sue J.} and Harper, {Diane M.} and Walter Kinney and Moscicki, {Anna Barbara} and Noller, {Kenneth L.} and Wheeler, {Cosette M.} and Terri Ades and Andrews, {Kimberly S.} and Doroshenk, {Mary K.} and Kahn, {Kelly Green} and Christy Schmidt and Omar Shafey and Smith, {Robert A.} and Partridge, {Edward E.} and Francisco Garcia",
year = "2007",
month = "1",
day = "1",
doi = "10.3322/canjclin.57.1.7",
language = "English (US)",
volume = "57",
pages = "7--28",
journal = "CA Cancer Journal for Clinicians",
issn = "0007-9235",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - American Cancer Society Guideline for Human Papillomavirus (HPV) Vaccine Use to Prevent Cervical Cancer and Its Precursors

AU - Saslow, Debbie

AU - Castle, Philip E.

AU - Cox, J. Thomas

AU - Davey, Diane D.

AU - Einstein, Mark H.

AU - Ferris, Daron Gale

AU - Goldie, Sue J.

AU - Harper, Diane M.

AU - Kinney, Walter

AU - Moscicki, Anna Barbara

AU - Noller, Kenneth L.

AU - Wheeler, Cosette M.

AU - Ades, Terri

AU - Andrews, Kimberly S.

AU - Doroshenk, Mary K.

AU - Kahn, Kelly Green

AU - Schmidt, Christy

AU - Shafey, Omar

AU - Smith, Robert A.

AU - Partridge, Edward E.

AU - Garcia, Francisco

PY - 2007/1/1

Y1 - 2007/1/1

N2 - The American Cancer Society (ACS) has developed guidelines for the use of the prophylactic human papillomavirus (HPV) vaccine for the prevention of cervical intraepithelial neoplasia and cervical cancer. These recommendations are based on a formal review of the available evidence. They address the use of prophylactic HPV vaccines, including who should be vaccinated and at what age, as well as a summary of policy and implementation issues. Implications for screening are also discussed.

AB - The American Cancer Society (ACS) has developed guidelines for the use of the prophylactic human papillomavirus (HPV) vaccine for the prevention of cervical intraepithelial neoplasia and cervical cancer. These recommendations are based on a formal review of the available evidence. They address the use of prophylactic HPV vaccines, including who should be vaccinated and at what age, as well as a summary of policy and implementation issues. Implications for screening are also discussed.

UR - http://www.scopus.com/inward/record.url?scp=33846459369&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846459369&partnerID=8YFLogxK

U2 - 10.3322/canjclin.57.1.7

DO - 10.3322/canjclin.57.1.7

M3 - Review article

VL - 57

SP - 7

EP - 28

JO - CA Cancer Journal for Clinicians

JF - CA Cancer Journal for Clinicians

SN - 0007-9235

IS - 1

ER -